speb/financial-data huggingface dataset:
Financial scorecard for XPOF (Consumer Cyclical — Leisure, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 6.32
Market cap: 310345664 (USD: 310345664)
Debt to equity: -1.405527835428473
Current ratio: 0.76
Interest coverage ratio: 0.6800055195253208
Buffett classification: The Great
Analyst consensus upside (%): 19.767441860465123
Rule of 40 score: -67.1555216006202
Altman Z-score: -2.7508703327736974 (Distress Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 1383.2019405700426, earnings yield % 6.338935749354306, rank 320
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.6048094810823585
Total shareholder yield (%): 0.6048094810823585 (Low Return)
Momentum (%): 1m -10.099573257467993, 3m -7.058823529411757, 6m -20.30264817150062, 12m -40.48964218455743, composite -20.388538275696465 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): -21.030656972282557
Revenue deceleration: no
Accrual ratio: 0.0652089629766016
FCF conversion rate: 31.042758620689654
Beneish M-score: -1.8217276510333642 (Likely Safe)
Net margin (%): -1.1941232664624304
Asset turnover: 0.18176837510497174
ROE archetype: Standard Business
FCF z-score: 4.417386680651881
Treasury beta 1y: -0.00191694424109625 (R-squared: 0.00011559048900616063)
Insider 90-day net shares: 200005 (net value USD: 963887.00)
ROIC (%): 30.265906342381083 (pretax: 38.31127385111529)
Incremental ROIC 3y (%): 11.969317885724053 (pretax: 13.885944456222173)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 5.673758865248227, revenue growth 1y 40.42553191489361, 6m momentum 65.95744680851064
Sector percentiles: P/E , 6m momentum 66.1682892906815
Industry median P/E: 1.0205229016661044; industry median ROIC: 5.789930606709577
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.08662394138721355
Base cash flow: -25345000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ZAG.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.02777777777777778
Market cap: 33367676 (USD: 21808938.562091503)
P/E ratio: 0.13071895424836602
Current ratio: 21.61
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 34.259259259259274, 3m 29.62962962962964, 6m -18.888888888888893, 12m 109.72222222222223, composite 22.315879097488295 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.0006110363823948419 (R-squared: 1.7987241457956217e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 0.9915014164305949, P/B , ROIC , revenue growth 1y , 6m momentum 25.07082152974504
Sector percentiles: P/E 8.134369794558578, 6m momentum 42.92059966685175
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.07880000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ZAU.V (Basic Materials — Gold, Canada)
Report date: 2023-03-31 (annual)
Stock price: 0.2127659574468085
Market cap: 23036046 (USD: 17063737.777777776)
Debt to equity: -0.09225363613320013
Current ratio: 0.38
Interest coverage ratio: -155.54005258545135
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -67.2884649589294 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.025366853321963367
Total shareholder yield (%): 0.025366853321963367 (Low Return)
Momentum (%): 1m -5.585106382978725, 3m -16.717325227963514, 6m 46.80851063829784, 12m 141.13475177304966, composite 61.83008214773273 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -2.4645772764504987
FCF conversion rate: 0.4885053606255066
Beneish M-score: -22.527589936229422 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: -0.007120807901737149 (R-squared: 0.0007262184995721631)
Insider 90-day net shares: 2990779 (net value USD: 814960.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 2.4079320113314444
Sector percentiles: P/E , 6m momentum 4.775124930594115
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -1025325.925925926
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ZBIO (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 30.39
Market cap: 1918623232 (USD: 1918623232)
P/B ratio: 3.6752559199771313
Debt to equity: 0.7945
Current ratio: 11.94
Interest coverage ratio: -11.664907253807872
Return on net tangible assets (%): -24.114355817990702
Buffett classification: The Gruesome
Analyst consensus upside (%): 122.50639386189258
Rule of 40 score: 0
Altman Z-score: 1.9431257245550486 (Grey Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -13.838204164933202
Total shareholder yield (%): -13.838204164933202 (Minimal or Negative)
Momentum (%): 1m 39.40366972477064, 3m 67.06981858163826, 6m 51.26928820308612, 12m 86.21323529411765, composite 50.63917938575779 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 9, recommendation: Short
Revenue growth 1y (%): -100
Revenue deceleration: no
Accrual ratio: -0.010234044772399016
FCF conversion rate: 0.9285193920011854
Beneish M-score: -2.9103731132329975 (Likely Safe)
ROE (%): -28.02449249359399
Asset turnover: 0
Equity multiplier (leverage): 1.9573959337200872
ROE archetype: Low Return
Treasury beta 1y: -0.0015507208277551721 (R-squared: 3.7469217865511395e-05)
Insider 90-day net shares: 402768 (net value USD: 7671338.00)
Incremental ROIC 3y (%): -67.98714659454266 (pretax: -86.05967923359832)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 38.628158844765345, ROIC , revenue growth 1y 29.693140794223826, 6m momentum 8.303249097472925
Sector percentiles: P/E , 6m momentum 6.053008595988539
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10436466986294132
Base cash flow: -377699000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ZED.L (Basic Materials — Specialty Chemicals, United Kingdom)
Report date: 2025-05-31 (quarterly)
Stock price: 0
Market cap: 761526 (USD: 1029089.1891891892)
P/B ratio: 0
Debt to equity: 0.0076
Current ratio: 0.31
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.0910711693246706
Total shareholder yield (%): 2.0910711693246706 (Low Return)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.5215468353153554 (Likely Safe)
Equity multiplier (leverage): 1.8322196849204304
ROE archetype: Standard Business
Treasury beta 1y: 0.12463310184363945 (R-squared: 5.554757206634183e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -76.97025016903312 (pretax: -97.43069641649763)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 77.44186046511628, ROIC 86.04651162790698, revenue growth 1y , 6m momentum 
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.13752280743185413
Base cash flow: -1559493.6708860758
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 0QF.DE (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 54.625
Market cap: 19071531008 (USD: 19071531008)
P/B ratio: 2.62637810148395
Debt to equity: 0.1752
Current ratio: 2.41
Interest coverage ratio: -81.6470588235294
Return on net tangible assets (%): -18.591160220994478
Buffett classification: The Gruesome
Rule of 40 score: -267.68517908192285
Altman Z-score: 3.5089022332754385 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.03670392270585768
Total shareholder yield (%): 0.03670392270585768 (Low Return)
Momentum (%): 1m -12.329016961517416, 3m 7.672473068989219, 6m 12.478803294573632, 12m 58.6308507003758, composite 33.69670202273124 (Strong Uptrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 263.5514018691589
Revenue deceleration: no
Accrual ratio: -0.05464618484009066
FCF conversion rate: 0.5152643335815339
Beneish M-score: -3.521226253848143 (Likely Safe)
ROE (%): -16.72686511396189
Net margin (%): -345.24421593830334
Asset turnover: 0.03265340384453958
Equity multiplier (leverage): 1.4837464192302903
ROE archetype: Low Return
Treasury beta 1y: -0.25594072777468346 (R-squared: 0.01332694549914702)
Insider 90-day net shares: -178424 (net value USD: -9799227.00)
ROIC (%): -58.43262752646776 (pretax: -73.96535129932627)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 30.324909747292416, ROIC 20.75812274368231, revenue growth 1y 2.0758122743682312, 6m momentum 19.67509025270758
Sector percentiles: P/E , 6m momentum 18.696275071633238
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0897746166203901
Base cash flow: -2799000000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1274.HK (Consumer Cyclical — Auto Parts, China)
Report date: 2025-12-31 (annual)
Stock price: 0.4094387755102041
Market cap: 792389120 (USD: 113198445.71428572)
P/B ratio: 1.5996252351230635
Debt to equity: 0.5505
Current ratio: 2.1
Interest coverage ratio: -69.71515679442508
Return on net tangible assets (%): -74.94061384051474
Buffett classification: The Gruesome
Analyst consensus upside (%): 1506.8740031897928
Rule of 40 score: -56.75925753315141
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.510607717581988
Debt paydown yield (%): -21.953573268067746
Total shareholder yield (%): -21.44296555048576 (Minimal or Negative)
Momentum (%): 1m -5.588235294117644, 3m -16.94545045997673, 6m -48.738002424083604, 12m -79.83629618723273, composite -48.108752938154204 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 1, short score 2, recommendation: Neutral
Revenue growth 1y (%): -16.371319046027565
Revenue CAGR 3y (%): -9.13051248072585
Revenue deceleration: yes
Revenue growth consistency score: 8.222132861483052
Accrual ratio: -0.011088404170310331
FCF conversion rate: 0.9568980443837355
Beneish M-score: -1.0267567101818362 (Strong Manipulation Signal)
ROE (%): -47.89325269987262
Net margin (%): -41.559069771160665
Asset turnover: 0.6190222423194535
Equity multiplier (leverage): 1.8616681178664818
ROE archetype: Low Return
Treasury beta 1y: 0.12834989268325483 (R-squared: 0.0032873544085885143)
Insider 90-day net shares: 340100 (net value USD: 157519.00)
ROIC (%): -41.66989826719426 (pretax: -52.74670666733451)
Incremental ROIC 3y (%): -46.066802510179826 (pretax: -58.31240824073396)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 51.790633608815426, ROIC 90.35812672176309, revenue growth 1y 63.63636363636363, 6m momentum 86.77685950413223
Sector percentiles: P/E , 6m momentum 83.41446453407511
Industry median P/E: 0.2842479295922772; industry median ROIC: 7.591641841963527
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.13707360093338594
Base cash flow: -81664285.71428572
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1477.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 0.6887755102040817
Market cap: 4341177856 (USD: 620168265.1428572)
P/B ratio: 1.4542130793637247
Debt to equity: 0.051
Current ratio: 3.7
Interest coverage ratio: -64.0118609406953
Return on net tangible assets (%): -4.07115210104265
Buffett classification: The Gruesome
Analyst consensus upside (%): 915.6054054054055
Rule of 40 score: 47.84921806640987
Altman Z-score: 4.905698757672736 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -2.4483265309695
Total shareholder yield (%): -2.4483265309695 (Minimal or Negative)
Momentum (%): 1m 16.379310344827594, 3m -28.09183673469387, 6m -25.9993253499747, 12m -41.736123328641796, composite -34.675795524821496 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 101.00890437290255
Revenue CAGR 3y (%): 71.35333548663164
Revenue deceleration: no
Revenue growth consistency score: 25.50659126713094
Beneish M-score: -2.6855304953341803 (Likely Safe)
ROE (%): -4.351659786868075
Net margin (%): -19.7450867281986
Asset turnover: 0.20359602341253352
Equity multiplier (leverage): 1.0824967420663887
ROE archetype: Low Return
Treasury beta 1y: 0.0653763019732696 (R-squared: 0.001439704415131297)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -3.723286313241561 (pretax: -4.713020649672862)
Incremental ROIC 3y (%): 12.7570537326779 (pretax: 16.148169281870757)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 16.335740072202164, ROIC 10.469314079422382, revenue growth 1y 5.595667870036101, 6m momentum 48.55595667870036
Sector percentiles: P/E , 6m momentum 55.08595988538681
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0690872022286887
Base cash flow: -6280857.142857144
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 1KT.DE (Technology — Scientific & Technical Instruments, United States)
Report date: 2026-04-30 (quarterly)
Stock price: 319.9431818181818
Market cap: 48115585024 (USD: 48115585024)
P/E ratio: 60.71047578408364
P/B ratio: 8.931370731028201
Debt to equity: 0.4364
Current ratio: 1.9
Interest coverage ratio: 16.28
Return on net tangible assets (%): 25.236406619385342
Buffett classification: The Great
Rule of 40 score: 31.424322947000583
Altman Z-score: 6.7635775700385485 (Safe Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 12.134764460345854, earnings yield % 0.839753705294091, rank 840
Dividend yield (%): 0
Buyback yield (%): 0.4634672942015936
Debt paydown yield (%): 0.02701827275614671
Total shareholder yield (%): 0.4904855669577403 (Low Return)
Momentum (%): 1m -10.177061732333707, 3m -3.303062251401745, 6m 49.52259981606254, 12m 69.04009481940237, composite 44.80403542588281 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 12, short score 2, recommendation: Long
Revenue growth 1y (%): 31.47013782542114
Net income growth 1y (%): 35.79766536964981
Revenue deceleration: no
Revenue growth consistency score: 5.80080272114294
Accrual ratio: -0.010594771523321419
FCF conversion rate: 1.3524355300859598
Beneish M-score: -2.4947285131987424 (Likely Safe)
ROE (%): 5.567964262922782
Net margin (%): 20.326150262085033
Asset turnover: 0.14789611955725915
Equity multiplier (leverage): 1.8521857051691129
ROE archetype: Standard Business
P/E z-score: 4.518351517788779
FCF z-score: 4.518351517788781
Treasury beta 1y: 0.01998901011814124 (R-squared: 0.0002915194133890611)
Insider 90-day net shares: -5507 (net value USD: -1904670.00)
ROIC (%): 10.367708226080335 (pretax: 12.90893015030946)
Incremental ROIC 3y (%): -17.489921486119048 (pretax: -17.289543223858058)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 50.36496350364964, P/B 62.77372262773723, ROIC 27.73722627737226, revenue growth 1y 7.2992700729927, 6m momentum 10.218978102189782
Sector percentiles: P/E 50.01668335001669, 6m momentum 9.743076409743075
Industry median P/E: 0.9334334334334333; industry median ROIC: 7.349148361525377
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10659876126733614
Base cash flow: 998000000
DCF price per share: base 65.51282459440728, conservative 58.86239785512867, aggressive 73.23076926796779
Financial scorecard for 2187.HK (Basic Materials — Building Materials, China)
Report date: 2025-12-31 (annual)
Stock price: 0.06887755102040817
Market cap: 484704032 (USD: 69243433.14285715)
P/B ratio: 1.3906119272746695
Debt to equity: 1.6595
Current ratio: 0.84
Interest coverage ratio: -2.9502044916409558
Return on net tangible assets (%): -124.82701435351977
Buffett classification: The Gruesome
Rule of 40 score: -22.849448865717463
Altman Z-score: 0.4816593825337644 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -32.30600459484418
Total shareholder yield (%): -32.30600459484418 (Minimal or Negative)
Momentum (%): 1m 0, 3m -30.857535321821032, 6m -31.122448979591834, 12m 12.643494897959195, composite -16.445496467817893 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue growth 1y (%): -0.6686522637037062
Revenue CAGR 3y (%): -4.655693233145208
Net income CAGR 3y (%): nan
Revenue deceleration: yes
Revenue growth consistency score: 15.770871063639492
Beneish M-score: -2.130085900877858 (Likely Safe)
ROE (%): -17.168992140474664
Net margin (%): -10.588316166122166
Asset turnover: 0.4654649961891259
Equity multiplier (leverage): 3.4836207937293038
ROE archetype: Low Return
Treasury beta 1y: -0.14118506676153425 (R-squared: 0.00533577347842026)
Insider 90-day net shares: -5700000 (net value USD: -685710.00)
ROIC (%): -4.1713610230370834 (pretax: -5.2802038266292195)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 50.79365079365079, ROIC 82.53968253968253, revenue growth 1y 37.301587301587304, 6m momentum 84.12698412698413
Sector percentiles: P/E , 6m momentum 55.247084952803995
Industry median P/E: 0.40903784698558243; industry median ROIC: 6.160009846970938
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.052303869714893536
Base cash flow: -31183571.42857143
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2405.HK (Communication Services — Advertising Agencies, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 0.06887755102040817
Market cap: 432000032 (USD: 55526996.401028275)
P/B ratio: 40.06259780907668
Debt to equity: 0.032799999999999996
Current ratio: 11.41
Interest coverage ratio: -2.456218905472637
Return on net tangible assets (%): -14.964707847805203
Buffett classification: The Gruesome
Rule of 40 score: 1951.9322063185184
Altman Z-score: 66.8817920542836 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 23.698920185150627
Total shareholder yield (%): 23.698920185150627 (High Return)
Momentum (%): 1m -15.625, 3m -17.029042386185232, 6m -40.306122448979586, 12m -80.89438955794333, composite -44.89715946177329 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 7, short score 5, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.6647094586658933
FCF conversion rate: -20.703173204054647
Beneish M-score: -16.808272234589563 (Likely Safe)
Equity multiplier (leverage): 4.595143025074119
ROE archetype: Standard Business
FCF z-score: 2.4216117539623485
Treasury beta 1y: -0.04736991527343045 (R-squared: 0.0003837444479708081)
Insider 90-day net shares: 3976000 (net value USD: 499458.00)
ROIC (%): -59.17508724017598 (pretax: -74.90517372174176)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 68.28358208955224, ROIC 72.76119402985076, revenue growth 1y , 6m momentum 76.49253731343283
Sector percentiles: P/E , 6m momentum 73.39300244100895
Industry median P/E: 0.20627847567967422; industry median ROIC: 5.9821146700167755
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.05
Base cash flow: -460539.84575835476
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2643.HK (Technology — Software - Application, China)
Report date: 2025-12-31 (annual)
Stock price: 1.8494897959183674
Market cap: 8428283392 (USD: 1204040484.5714285)
Debt to equity: -1.7849850108987269
Current ratio: 0.42
Interest coverage ratio: 13.070139341810831
Buffett classification: The Great
Analyst consensus upside (%): 1258.6473333333333
Rule of 40 score: 42.163922441319706
Altman Z-score: 1.9913161651482683 (Grey Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.4312024442358062
Total shareholder yield (%): -3.4312024442358062 (Minimal or Negative)
Momentum (%): 1m -41.05691056910569, 3m -41.981149430926216, 6m -60.67060957425501, 12m -64.71811689438837, composite -47.59807313050762 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 1, short score 5, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.11388237531909827
FCF conversion rate: 0.15893650134037335
Beneish M-score: 0.5947958431117311 (Strong Manipulation Signal)
ROE archetype: Standard Business
Treasury beta 1y: -0.14168236449089372 (R-squared: 0.003537822970947892)
Insider 90-day net shares: -621731 (net value USD: -2443278.00)
ROIC (%): 172.22028108201675 (pretax: 218.0003558000212)
Incremental ROIC 3y (%): 285.34484135439124 (pretax: 361.1960017144193)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E , P/B , ROIC 2.8301886792452833, revenue growth 1y , 6m momentum 90.29649595687331
Sector percentiles: P/E , 6m momentum 81.64831498164831
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09395480429070051
Base cash flow: -33517428.571428575
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2652.HK (Healthcare — Drug Manufacturers - Specialty & Generic, China)
Report date: 2025-12-31 (annual)
Stock price: 2.010204081632653
Market cap: 5786972672 (USD: 826710381.7142857)
P/E ratio: 462.72493573264774
P/B ratio: 5.678990518656459
Debt to equity: 0.08220000000000001
Current ratio: 4.59
Interest coverage ratio: -2.712204724409449
Return on net tangible assets (%): -3.171961390114249
Buffett classification: The Gruesome
Rule of 40 score: -88.18745071884099
Altman Z-score: 11.344408831499766 (Safe Zone)
Piotroski F-score: 3 (Weak)
Magic formula: return on capital % 1.3914532525032015, earnings yield % 0.024461779331096264, rank 2815
Dividend yield (%): 0
Buyback yield (%): 0.03604648091899612
Debt paydown yield (%): -1.2046464636188214
Total shareholder yield (%): -1.1685999826998252 (Minimal or Negative)
Momentum (%): 1m -17.573221757322184, 3m -24.181609059808903, 6m -55.405028905760254, 12m , composite -39.79331898278458 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): -25.782619508333283
Net income growth 1y (%): -87.71102048558421
Revenue CAGR 3y (%): 7.19593593191763
Revenue deceleration: yes
Revenue growth consistency score: 41.20721683580484
Accrual ratio: 0.17690949287517221
FCF conversion rate: -105.20080482897384
Beneish M-score: 2.9015826811598626 (Strong Manipulation Signal)
ROE (%): 0.2097920662308482
Net margin (%): 0.5745385773176331
Asset turnover: 0.28993732979118697
Equity multiplier (leverage): 1.259405920979625
ROE archetype: Low Return
P/E z-score: 1.6779006846328335
Treasury beta 1y: 0.09562890552235095 (R-squared: 0.0034432353437723376)
Insider 90-day net shares: 8500 (net value USD: 24707.00)
ROIC (%): -0.5665201695508071 (pretax: -0.7171141386719077)
Incremental ROIC 3y (%): 14.805383965332625 (pretax: 18.74099236118054)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 56.89149560117303, P/B 69.20821114369502, ROIC 60.70381231671554, revenue growth 1y 66.86217008797654, 6m momentum 88.26979472140762
Sector percentiles: P/E 34.59885386819484, 6m momentum 72.42120343839542
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1015845145349847
Base cash flow: -5951714.285714285
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2659.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 2.2002551020408165
Market cap: 5599518208 (USD: 799931172.5714285)
P/B ratio: 6.703930674306363
Debt to equity: 0.1979
Current ratio: 4.12
Interest coverage ratio: -61.14546367592902
Return on net tangible assets (%): -32.34184488357789
Buffett classification: The Gruesome
Rule of 40 score: -143.18786209547397
Altman Z-score: 4.741557257554785 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -1.3323823880884764
Total shareholder yield (%): -1.3323823880884764 (Minimal or Negative)
Momentum (%): 1m 4.103802051901038, 3m -77.87026660375133, 6m -82.71702940995128, 12m , composite -80.2936480068513 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 732.186456400742
Revenue deceleration: no
Revenue growth consistency score: 527.226674791486
Beneish M-score: -2.5242865752608834 (Likely Safe)
ROE (%): -31.041528038053883
Net margin (%): -804.1785336479778
Asset turnover: 0.02789609131455783
Equity multiplier (leverage): 1.383716945388996
ROE archetype: Low Return
Treasury beta 1y: 0.037741904402190225 (R-squared: 0.00016375686518955523)
Insider 90-day net shares: 250000 (net value USD: 681840.00)
ROIC (%): -49.94817272642303 (pretax: -63.22553509673801)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 52.978339350180505, ROIC 20.03610108303249, revenue growth 1y 1.083032490974729, 6m momentum 77.25631768953069
Sector percentiles: P/E , 6m momentum 78.93982808022922
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10120707653095014
Base cash flow: -73013285.71428572
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 2677.HK (Healthcare — Medical Care Facilities, China)
Report date: 2025-12-31 (annual)
Stock price: 3.357142857142857
Market cap: 1699757312 (USD: 242822473.14285713)
Debt to equity: -0.18047622408502403
Current ratio: 0.25
Interest coverage ratio: 2.4253415355117043
Return on net tangible assets (%): -12.255190172531178
Buffett classification: The Gruesome
Rule of 40 score: 29.505350280971445
Altman Z-score: -2.244919976876292 (Distress Zone)
Piotroski F-score: 9 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.139978342753228
Total shareholder yield (%): 2.139978342753228 (Low Return)
Momentum (%): 1m -7.2586328400281825, 3m -17.44212132089017, 6m , 12m , composite -17.44212132089017 ()
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 5, short score 6, recommendation: Neutral
Revenue growth 1y (%): 15.812346144869949
Net income growth 1y (%): 68.07166295908016
Revenue CAGR 3y (%): 30.78147017007671
Revenue deceleration: yes
Revenue growth consistency score: 13.933739909917664
Accrual ratio: -0.00820930058675864
FCF conversion rate: 1.0792365100989163
Beneish M-score: -2.7560436052341024 (Likely Safe)
Net margin (%): 12.687676897482358
Asset turnover: 0.8165799424707132
ROE archetype: Standard Business
P/E z-score: 1.3492413889936794
FCF z-score: 1.3492413889936805
Treasury beta 1y: -0.11416803230702843 (R-squared: 0.006176486962786556)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 18.095238095238095, 6m momentum 
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1004772371746186
Base cash flow: 31295571.428571433
DCF price per share: base 16.98749572211194, conservative 10.011416768914627, aggressive 29.32716030024437
Financial scorecard for 5GG.AX (Communication Services — Telecom Services, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 6064403 (USD: 4042935.3333333335)
P/B ratio: 0.841404098519871
Debt to equity: 0.41100000000000003
Current ratio: 0.63
Interest coverage ratio: -10.125198098256734
Return on net tangible assets (%): -38.81982519950058
Buffett classification: The Gruesome
Rule of 40 score: -30.585084941369185
Altman Z-score: -1.2712545528670582 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 4.913921452779441
Debt paydown yield (%): -16.78058638428153
Total shareholder yield (%): -11.86666493150209 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -51.38888888888889, 6m -66.20370370370371, 12m -73.78472222222221, composite -63.852703277990635 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 6.528218382067275
Revenue CAGR 3y (%): 19.25494259175544
Revenue deceleration: yes
Revenue growth consistency score: 18.628154422643824
Accrual ratio: 0.030573142292078564
FCF conversion rate: 1.2139724310776943
Beneish M-score: -3.2779455207236157 (Likely Safe)
ROE (%): -22.522619662456492
Net margin (%): -30.571784311847523
Asset turnover: 0.4673706861955962
Equity multiplier (leverage): 1.5762919092103738
ROE archetype: Low Return
Treasury beta 1y: 0.001279827649404822 (R-squared: 5.71050153699944e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -18.219362523914377 (pretax: -23.06248420748655)
Incremental ROIC 3y (%): 23.537331610299216 (pretax: 29.794090645948362)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 15.546218487394958, ROIC 66.80672268907563, revenue growth 1y 21.428571428571427, 6m momentum 71.84873949579831
Sector percentiles: P/E , 6m momentum 81.61106590724167
Industry median P/E: 6.173333333333333; industry median ROIC: 6.697966332884982
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.09599430389781748
Base cash flow: -4767333.333333334
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 6681.HK (Healthcare — Health Information Services, China)
Report date: 2025-12-31 (annual)
Stock price: 0.21045918367346939
Market cap: 2241158656 (USD: 320165522.28571427)
P/B ratio: 82.82089485766672
Debt to equity: 5.923500000000001
Current ratio: 1.56
Interest coverage ratio: -10.412157091636788
Return on net tangible assets (%): -357.16867043012024
Buffett classification: The Gruesome
Rule of 40 score: -40.968817937433016
Altman Z-score: -2.4343325873864616 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -6.755967845187478
Total shareholder yield (%): -6.755967845187478 (Minimal or Negative)
Momentum (%): 1m -13.612565445026181, 3m -58.59559275971695, 6m -71.64798561911812, 12m -71.26774622892636, composite -65.66127265097519 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 17, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.16687335570135023
FCF conversion rate: 0.6534534286558196
Beneish M-score: -1.5086386195675383 (Possible Manipulation)
Equity multiplier (leverage): 4.277708248443289
ROE archetype: Standard Business
Treasury beta 1y: 0.3242232871935293 (R-squared: 0.012966914124526737)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -85.54614000476943 (pretax: -108.28625317059422)
Incremental ROIC 3y (%): -8.869438728188474 (pretax: -11.227137630618321)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 60.526315789473685, ROIC 54.736842105263165, revenue growth 1y , 6m momentum 77.36842105263158
Sector percentiles: P/E , 6m momentum 76.79083094555874
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09952036261241459
Base cash flow: -43204142.85714286
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 8267.HK (Communication Services — Electronic Gaming & Multimedia, China)
Report date: 2025-12-31 (annual)
Stock price: 0.025510204081632654
Market cap: 73529096 (USD: 10504156.57142857)
P/B ratio: 0.4246181087364363
Debt to equity: 0.0226
Current ratio: 1.29
Interest coverage ratio: -586.1509433962264
Return on net tangible assets (%): -5.950332951954499
Buffett classification: The Gruesome
Rule of 40 score: -351.17838162251275
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -6.746988974269451
Total shareholder yield (%): -6.746988974269451 (Minimal or Negative)
Momentum (%): 1m -9.090909090909088, 3m -28.662536443148696, 6m -47.63694951664876, 12m -67.70078999341672, composite -46.92345165085195 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -70.46848269122985
Revenue CAGR 3y (%): -16.66618063894819
Revenue deceleration: yes
Revenue growth consistency score: 78.59361207436088
Beneish M-score: -2.4820206176415933 (Likely Safe)
ROE (%): -4.636720939338843
Net margin (%): -24.87789544948982
Asset turnover: 0.13453910492508245
Equity multiplier (leverage): 1.3853157961570561
ROE archetype: Low Return
Treasury beta 1y: 0.1276242233476233 (R-squared: 0.0021372479398693543)
Insider 90-day net shares: 28129500 (net value USD: 933899.00)
ROIC (%): -15.887965300705636 (pretax: -20.11134848190587)
Incremental ROIC 3y (%): 39.645790066367226 (pretax: 50.18454438780662)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 12.8, ROIC 65.60000000000001, revenue growth 1y 36.8, 6m momentum 81.6
Sector percentiles: P/E , 6m momentum 76.40358014646054
Industry median P/E: 0.634833652550188; industry median ROIC: 5.123301786907901
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.06233057109797143
Base cash flow: -1032714.2857142858
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 8425.HK (Industrials — Rental & Leasing Services, Hong Kong)
Report date: 2026-03-31 (annual)
Stock price: 0.011479591836734694
Market cap: 33840000 (USD: 4316326.530612245)
P/E ratio: 1.0204081632653061
P/B ratio: 0.31546601503917104
Debt to equity: 0.5305
Current ratio: 1.08
Interest coverage ratio: 1.429759704251386
Return on net tangible assets (%): 18.332267097356084
Buffett classification: The Gruesome
Rule of 40 score: 19.052535822468947
Altman Z-score: 1.211591851094323 (Distress Zone)
Piotroski F-score: 8 (Strong)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 7.0638784055619395
Total shareholder yield (%): 7.0638784055619395 (Moderate Return)
Momentum (%): 1m 28.57142857142856, 3m 12.356505102040815, 6m -0.5102040816326534, 12m 50.19132653061226, composite 9.553925736961455 (Moderate Uptrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 6, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.4757164798151527 (Likely Safe)
Equity multiplier (leverage): 1.8356867881617893
ROE archetype: Standard Business
P/E z-score: 3.0442345408026967
FCF z-score: 4.140931338829291
Treasury beta 1y: 0.007186401886005432 (R-squared: 4.7098393564869205e-06)
Insider 90-day net shares: 80000000 (net value USD: 408000.00)
ROIC (%): 2.764416262026118 (pretax: 3.499261091172301)
Incremental ROIC 3y (%): 7.728936154980008 (pretax: 1.929900413366024)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 28.846153846153843, P/B 11.538461538461538, ROIC 51.92307692307693, revenue growth 1y , 6m momentum 37.5
Sector percentiles: P/E 38.17204301075269, 6m momentum 40.2457757296467
Industry median P/E: 1.3202365863962822; industry median ROIC: 4.993191103041307
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: 2229591.836734694
DCF price per share: base 0.02841658166121229, conservative 0.02084912618930618, aggressive 0.04033211509572239
Financial scorecard for 8446.HK (Industrials — Rental & Leasing Services, Hong Kong)
Report date: 2025-12-31 (annual)
Stock price: 0.010204081632653062
Market cap: 92258648 (USD: 11858438.046272494)
P/E ratio: 0.5141388174807198
P/B ratio: 0.34531985199372345
Debt to equity: 0.057699999999999994
Current ratio: 1.99
Interest coverage ratio: 42.09980397331021
Return on net tangible assets (%): 0.4434359679435864
Buffett classification: The Gruesome
Rule of 40 score: 64.27262496200444
Altman Z-score: 1.2252806023104945 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 36.51925462815999
Total shareholder yield (%): 36.51925462815999 (High Return)
Momentum (%): 1m -19.999999999999996, 3m -20.10204081632653, 6m -38.77551020408163, 12m -33.248299319727884, composite -25.145975056689338 (Strong Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 6, short score 4, recommendation: Neutral
Revenue growth 1y (%): 0.8027125615643449
Net income growth 1y (%): -38.826869344066864
Revenue CAGR 3y (%): 101.67467701459981
Revenue deceleration: yes
Revenue growth consistency score: 197.293960298067
Beneish M-score: -2.8498074631446286 (Likely Safe)
ROE (%): 7.132727243569136
Net margin (%): 15.68715591869983
Asset turnover: 0.3194964276495858
Equity multiplier (leverage): 1.423132697945336
ROE archetype: Standard Business
P/E z-score: 2.5400344956107586
FCF z-score: 2.5400344956107603
Treasury beta 1y: 0.020859620664096416 (R-squared: 5.2642963820820716e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 7.181490043891758 (pretax: 8.515112333653848)
Incremental ROIC 3y (%): 14.467061450092494 (pretax: 17.62300781450125)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 25.961538461538463, P/B 12.5, ROIC 28.846153846153843, revenue growth 1y 38.46153846153847, 6m momentum 71.15384615384616
Sector percentiles: P/E 33.99897593445981, 6m momentum 79.621095750128
Industry median P/E: 1.3202365863962822; industry median ROIC: 4.993191103041307
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05
Base cash flow: 138630.71979434416
DCF price per share: base 0.003265869220882, conservative 0.0018262950442448586, aggressive 0.006442549407641803
Financial scorecard for 8455.HK (Industrials — Consulting Services, Hong Kong)
Report date: 2026-03-31 (annual)
Stock price: 0.005102040816326531
Market cap: 40320000 (USD: 5142857.142857143)
Debt to equity: -0.968667255075022
Current ratio: 0.47
Interest coverage ratio: -41.75
Buffett classification: The Gruesome
Rule of 40 score: 0.4308192272692226
Altman Z-score: -0.7178622832199455 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.050117058391478
Total shareholder yield (%): 3.050117058391478 (Low Return)
Momentum (%): 1m -42.85714285714286, 3m -50.06377551020408, 6m -63.821892393320965, 12m -42.78425655976677, composite -37.919372294372295 (Flat)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 9, recommendation: Short
Revenue growth 1y (%): 8.172160890100798
Revenue CAGR 3y (%): -2.772248495955998
Revenue deceleration: no
Revenue growth consistency score: 11.47003563984812
Beneish M-score: -2.9954611057792384 (Likely Safe)
Net margin (%): -9.243393030246654
Asset turnover: 4.6306870737162535
ROE archetype: Standard Business
Treasury beta 1y: 0.19972456502410496 (R-squared: 0.004019105633725164)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 21.428571428571427, 6m momentum 84.6938775510204
Sector percentiles: P/E , 6m momentum 85.45826932923707
Industry median P/E: 0.2845441962964237; industry median ROIC: 13.853275023936842
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10094692417393829
Base cash flow: -1150255.1020408163
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 9606.HK (Healthcare — Biotechnology, China)
Report date: 2025-12-31 (annual)
Stock price: 29.872448979591837
Market cap: 21189271552 (USD: 3027038793.142857)
P/B ratio: 10.057025775277626
Debt to equity: 0.0617
Current ratio: 3.65
Interest coverage ratio: -376.0338842975206
Return on net tangible assets (%): -107.06263132544443
Buffett classification: The Gruesome
Analyst consensus upside (%): 1030.3836557705135
Rule of 40 score: 0.8162989656166852
Altman Z-score: 7.8727361054041545 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.3940283468300404
Total shareholder yield (%): -0.3940283468300404 (Minimal or Negative)
Momentum (%): 1m 34.9078341013825, 3m -20.061081507107286, 6m -30.363089647096135, 12m -29.706617359173897, composite -32.77314212619845 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 6, short score 6, recommendation: Neutral
Revenue growth 1y (%): -0.523471573904355
Revenue CAGR 3y (%): 947.9084702036206
Revenue deceleration: yes
Revenue growth consistency score: 63046.89536976462
Accrual ratio: -0.9413574793104263
FCF conversion rate: -0.06969944431748244
Beneish M-score: -3.507718458796725 (Likely Safe)
Equity multiplier (leverage): 1.5123941056759185
ROE archetype: Standard Business
FCF z-score: 3.158344795765487
Treasury beta 1y: -0.032279733963235364 (R-squared: 0.0002022983999804352)
Insider 90-day net shares: 5442091 (net value USD: 112305556.00)
Incremental ROIC 3y (%): -18.799266127087407 (pretax: -23.796539401376478)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 57.5812274368231, ROIC , revenue growth 1y 17.870036101083034, 6m momentum 51.89530685920578
Sector percentiles: P/E , 6m momentum 58.3810888252149
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10180364570646981
Base cash flow: -370573285.71428573
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for 9880.HK (Industrials — Specialty Industrial Machinery, China)
Report date: 2025-12-31 (annual)
Stock price: 10.031887755102042
Market cap: 39592517632 (USD: 5656073947.428572)
P/B ratio: 6.712754670922568
Debt to equity: 0.16
Current ratio: 3.04
Interest coverage ratio: -211.77926549349655
Return on net tangible assets (%): -15.402977946659243
Buffett classification: The Gruesome
Analyst consensus upside (%): 844.2566904196358
Rule of 40 score: 0.23349372632532805
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0.15966400668824232
Buyback yield (%): 0
Debt paydown yield (%): 0.9069237143349377
Total shareholder yield (%): 1.06658772102318 (Low Return)
Momentum (%): 1m -18.665977249224394, 3m -25.190779883381907, 6m -45.660607993197274, 12m -15.139742588845875, composite -22.171963402561346 (Flat)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue growth 1y (%): 59.86046005664334
Revenue CAGR 3y (%): 25.427698902332875
Revenue deceleration: no
Revenue growth consistency score: 25.05975302999335
Accrual ratio: 0.06462206253125197
FCF conversion rate: 1.6967438434223416
Beneish M-score: -1.9756746684114275 (Likely Safe)
Equity multiplier (leverage): 1.556597958519873
ROE archetype: Standard Business
Treasury beta 1y: 0.14799287689525567 (R-squared: 0.006538399136873282)
Insider 90-day net shares: 1500 (net value USD: 23952.00)
ROIC (%): -12.243401984478812 (pretax: -15.4979771955428)
Incremental ROIC 3y (%): 10.237668803051788 (pretax: 12.959074434242767)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 69.55684007707129, ROIC 80.92485549132948, revenue growth 1y 2.697495183044316, 6m momentum 84.58574181117534
Sector percentiles: P/E , 6m momentum 81.95084485407065
Industry median P/E: 0.34832165205981025; industry median ROIC: 8.620128805291433
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.15
Base cash flow: -149467571.42857143
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AADHARHFC.NS (Financial Services — Mortgage Finance, India)
Report date: 2026-03-31 (annual)
Stock price: 5.109413707679604
Market cap: 216481873920 (USD: 2294212313.6922426)
P/E ratio: 0.1913415650490983
P/B ratio: 2.591589366476839
Debt to equity: 2.5557
Current ratio: 5.88
Interest coverage ratio: 1.8991756546818208
Return on net tangible assets (%): 14.714196459010132
Buffett classification: The Great
Analyst consensus upside (%): 12995.202628940624
Rule of 40 score: -75.74272194597908
Altman Z-score: 1.299260443803049 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.4113551847965122
Total shareholder yield (%): -3.4113551847965122 (Minimal or Negative)
Momentum (%): 1m -3.947462631454726, 3m -1.4859815550650486, 6m -0.12427005227485326, 12m -13.72809373783119, composite -3.9309454817010825 (Moderate Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 0, short score 8, recommendation: Short
Revenue growth 1y (%): 8.311312959436211
Net income growth 1y (%): 8.950803632216985
Revenue CAGR 3y (%): 16.148046740453825
Net income CAGR 3y (%): 20.514047216630125
Revenue deceleration: yes
Revenue growth consistency score: 7.514713193314456
Beneish M-score: -1.028093234255688 (Strong Manipulation Signal)
ROE (%): 15.04273307649456
Net margin (%): 32.35127411850838
Asset turnover: 0.1277859371228407
Equity multiplier (leverage): 3.638750662636782
ROE archetype: Leverage-Driven Returns
P/E z-score: 3.4412976509088358
Treasury beta 1y: 0.0002899893458987927 (R-squared: 2.0505022716039422e-05)
Insider 90-day net shares: -326191357 (net value USD: -1523868162.00)
ROIC (%): 7.998398857662988 (pretax: 10.261186387174662)
Incremental ROIC 3y (%): 8.381184528544344 (pretax: 10.834245517963744)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 15.217391304347828, P/B 44.565217391304344, ROIC 3.260869565217391, revenue growth 1y 23.91304347826087, 6m momentum 17.391304347826086
Sector percentiles: P/E 9.596482152095188, 6m momentum 40.76564924987067
Industry median P/E: 1.1112600720512609; industry median ROIC: 2.400679876577233
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.06714723585842869
Base cash flow: 117554048.32556169
DCF price per share: base 0.13155182697416068, conservative 0.049949752670351615, aggressive 0.28944600849103175